Moderna Inc (MRNA) Down 1.09% in Premarket Trading

Moderna Inc (MRNA) is down Thursday morning, with the stock decreasing -1.09% in pre-market trading to 220.45. MRNA's short-term technical score of 68 indicates that the stock has traded more bullishly over the last month than 68% of stocks on the market. In the Biotechnology industry, which ranks 140 out of 146 industries, the stock ranks higher than 93% of stocks. Moderna Inc has fallen 18.05% over the past month, closing at $282.02 on December 16. During this period of time, the stock fell as low as $213.86 and as high as $321.31. MRNA has an average analyst recommendation of Buy. The company has an average price target of $257.23.

MRNA has an Overall Score of 49. Find out what this means to you and get the rest of the rankings on MRNA!

See Full MRNA Report

Moderna Inc has a Long-Term Technical rank of 39. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 61% of the market scoring higher. In the Biotechnology industry which is number 143 by this metric, MRNA ranks better than 76% of stocks.

Important Dates for Investors in MRNA:

-Moderna Inc is set to release earnings on 2/2/2022. During their last earnings release the company posted EPS of $16.30. -We do not have a set dividend date for Moderna Inc at this time. Click Here To Get The Full Report on Moderna Inc (MRNA)